Total Payments
$17,482
2024 Payments
$78.90
Companies
28
Transactions
159
Medicare Patients
7,746
Medicare Billing
$927,479
Payment Breakdown by Category
Other$12,250 (70.1%)
Travel$2,609 (14.9%)
Food & Beverage$2,590 (14.8%)
Education$32.48 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,250 | 5 | 70.1% |
| Travel and Lodging | $2,609 | 9 | 14.9% |
| Food and Beverage | $2,590 | 143 | 14.8% |
| Education | $32.48 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Egalet US Inc | $15,690 | 59 | $0 (2018) |
| Zyla Life Sciences, Inc. | $209.65 | 38 | $0 (2020) |
| Relievant Medsystems, Inc. | $160.21 | 1 | $0 (2022) |
| Zimmer Biomet Holdings, Inc. | $149.98 | 5 | $0 (2019) |
| Horizon Therapeutics plc | $149.15 | 3 | $0 (2022) |
| Flexion Therapeutics, Inc. | $140.76 | 11 | $0 (2020) |
| Lilly USA, LLC | $138.24 | 9 | $0 (2018) |
| Pacira Pharmaceuticals Incorporated | $107.32 | 3 | $0 (2023) |
| Nevro Corp. | $102.91 | 1 | $0 (2021) |
| Radius Health, Inc. | $71.23 | 4 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $78.90 | 2 | SPINEFRONTIER, INC. ($62.09) |
| 2023 | $144.65 | 6 | Pacira Pharmaceuticals Incorporated ($92.22) |
| 2022 | $252.55 | 5 | Relievant Medsystems, Inc. ($160.21) |
| 2021 | $102.91 | 1 | Nevro Corp. ($102.91) |
| 2020 | $182.29 | 10 | Alpha Orthopedic Systems ($30.36) |
| 2019 | $506.43 | 48 | Zyla Life Sciences ($197.86) |
| 2018 | $11,302 | 45 | Egalet US Inc ($11,004) |
| 2017 | $4,912 | 42 | Egalet US Inc ($4,686) |
All Payment Transactions
159 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/16/2024 | SPINEFRONTIER, INC. | Inspan (Device) | Food and Beverage | Cash or cash equivalent | $62.09 | General |
| Category: Orthopedic | ||||||
| 02/27/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Neuromodulation | ||||||
| 12/04/2023 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $75.80 | General |
| Category: Pain Management | ||||||
| 10/23/2023 | Pacira Pharmaceuticals Incorporated | Exparel (Drug), Iovera, Zilretta | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Pain Management | ||||||
| 09/20/2023 | Sanara MedTech Inc. | CellerateRx (Device) | Food and Beverage | Cash or cash equivalent | $6.28 | General |
| Category: Collagen based wound filler | ||||||
| 09/20/2023 | Sanara MedTech Inc. | CellerateRx (Device) | Food and Beverage | Cash or cash equivalent | $0.25 | General |
| Category: Collagen based wound filler | ||||||
| 05/08/2023 | Sanara MedTech Inc. | CellerateRx (Device) | Food and Beverage | Cash or cash equivalent | $7.17 | General |
| Category: Collagen based wound filler | ||||||
| 04/20/2023 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $38.73 | General |
| Category: Pain management | ||||||
| 12/31/2022 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $23.48 | General |
| Category: Pain management | ||||||
| 10/17/2022 | Relievant Medsystems, Inc. | Intracept (Device), Intracept | Food and Beverage | Cash or cash equivalent | $160.21 | General |
| Category: Pain | ||||||
| 09/27/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Neuromodulation | ||||||
| 07/23/2022 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $41.33 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 05/18/2022 | Horizon Therapeutics plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: PENNSAID | ||||||
| 03/29/2021 | Nevro Corp. | Omnia (Device) | Food and Beverage | In-kind items and services | $102.91 | General |
| Category: Spinal Cord Stimulator | ||||||
| 08/27/2020 | Stryker Corporation | EVEREST XT (Device) | Food and Beverage | Cash or cash equivalent | $19.36 | General |
| Category: SPINE | ||||||
| 08/20/2020 | Alpha Orthopedic Systems | — | Food and Beverage | In-kind items and services | $30.36 | General |
| 06/09/2020 | Medtronic USA, Inc. | INTELLIS (Device) | Food and Beverage | In-kind items and services | $29.41 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 04/24/2020 | Zyla Life Sciences, Inc. | SPRIX (Drug) | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: Pain Medicine | ||||||
| 02/28/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Bone Health | ||||||
| 02/27/2020 | Horizon Therapeutics plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: DUEXIS | ||||||
| 02/25/2020 | Flexion Therapeutics, Inc. | Zilretta (Drug) | Food and Beverage | In-kind items and services | $12.55 | General |
| Category: Musculoskeletal | ||||||
| 02/10/2020 | Boston Scientific Corporation | SPECTRA WAVEWRITER (Device) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: PAIN MANAGEMENT | ||||||
| 01/30/2020 | Flexion Therapeutics, Inc. | Zilretta (Drug) | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: Musculoskeletal | ||||||
| 01/09/2020 | Radius Health, Inc. | — | Food and Beverage | In-kind items and services | $15.53 | General |
| 10/11/2019 | Zyla Life Sciences | ZORVOLEX (Drug) | Food and Beverage | In-kind items and services | $5.80 | General |
| Category: Pain Medicine | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,847 | 6,635 | $1.3M | $222,608 |
| 2022 | 23 | 2,051 | 7,292 | $1.4M | $262,528 |
| 2021 | 19 | 1,921 | 6,711 | $1.2M | $236,478 |
| 2020 | 23 | 1,927 | 5,796 | $1.2M | $205,865 |
Total Patients
7,746
Total Services
26,434
Medicare Billing
$927,479
Procedure Codes
85
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 146 | 205 | $266,080 | $41,493 | 15.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 275 | 407 | $125,763 | $35,894 | 28.5% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 129 | 174 | $215,006 | $29,848 | 13.9% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 33 | 54 | $87,210 | $16,400 | 18.8% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 74 | 91 | $91,364 | $15,503 | 17.0% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 124 | 165 | $106,140 | $15,398 | 14.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 111 | 111 | $51,948 | $12,196 | 23.5% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 58 | 72 | $78,546 | $11,420 | 14.5% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 32 | 56 | $37,072 | $9,765 | 26.3% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 45 | 57 | $46,063 | $7,126 | 15.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 92 | 99 | $20,988 | $6,317 | 30.1% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2023 | 56 | 69 | $38,625 | $6,043 | 15.6% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 40 | 44 | $14,300 | $3,703 | 25.9% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 31 | 43 | $17,820 | $3,530 | 19.8% |
| 64454 | Injection of anesthetic agent and/or steroid into knee nerve branch using imaging guidance | Office | 2023 | 14 | 14 | $13,168 | $2,306 | 17.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 38 | 44 | $11,132 | $2,051 | 18.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 279 | 1,700 | $5,100 | $1,442 | 28.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $5,490 | $1,252 | 22.8% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 22 | 22 | $2,508 | $607.32 | 24.2% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 230 | 3,190 | $15,950 | $312.20 | 2.0% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2022 | 154 | 220 | $269,598 | $44,912 | 16.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 253 | 397 | $122,673 | $35,741 | 29.1% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2022 | 150 | 188 | $230,408 | $31,612 | 13.7% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2022 | 72 | 100 | $123,717 | $17,926 | 14.5% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2022 | 145 | 183 | $115,834 | $17,390 | 15.0% |
About Dr. John Lavelle, DO
Dr. John Lavelle, DO is a Interventional Pain Medicine healthcare provider based in Knoxville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2008. The National Provider Identifier (NPI) number assigned to this provider is 1942462494.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Lavelle, DO has received a total of $17,482 in payments from pharmaceutical and medical device companies, with $78.90 received in 2024. These payments were reported across 159 transactions from 28 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($12,250).
As a Medicare-enrolled provider, Lavelle has provided services to 7,746 Medicare beneficiaries, totaling 26,434 services with total Medicare billing of $927,479. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Pain Medicine
- Other Specialties Physical Medicine & Rehabilitation
- Location Knoxville, TN
- Active Since 06/26/2008
- Last Updated 07/11/2025
- Taxonomy Code 208VP0014X
- Entity Type Individual
- NPI Number 1942462494
Products in Payments
- SPRIX (Drug) $15,763
- Intracept (Device) $160.21
- Zilretta (Drug) $140.76
- FORTEO (Drug) $138.24
- Omnia (Device) $102.91
- ZORVOLEX (Drug) $97.75
- Iovera (Device) $75.80
- Gel One (Biological) $68.60
- SPRINT PNS System (Device) $62.21
- Inspan (Device) $62.09
- BBA - Soft Tissues (Device) $42.28
- INTELLIS ADAPTIVESTIM (Device) $41.33
- INTELLIS (Device) $41.28
- coflex (Device) $39.61
- OXAYDO (Drug) $38.69
- Tymlos (Biological) $35.29
- PROCLAIM (Device) $32.55
- InViZia (Device) $31.80
- Blackhawk (Device) $28.24
- AccuFill (Device) $26.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Pain Medicine Doctors in Knoxville
Dr. Adolfo Cuadra, Md, MD
Interventional Pain Medicine — Payments: $11,665
Interventional Pain Medicine $11,665
Dr. James Fox, M.d, M.D
Interventional Pain Medicine — Payments: $5,644
Interventional Pain Medicine $5,644
Dr. Curtis Markham, M.d, M.D
Interventional Pain Medicine — Payments: $154.67
Interventional Pain Medicine $154.67